18-FDG-PET in a case of recurrent malignant schwannoma;Diagnóstico de recurrencia mediante FDG-PET en un caso clínico de schwannoma maligno

Revista Espanola de Medicina Nuclear

Volumn 24, Issue 2, 2005, Pages 127-130

  Santaella, Y ^a   Borrego, I ^a   Lopez J ^a   Ortiz, M J ^a   Vazquez R ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Positron emission tomography; Schwannoma; Soft tissue sarcoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; FEMALE; HUMAN; LIMB AMPUTATION; MALIGNANT NEURILEMOMA; POSITRON EMISSION TOMOGRAPHY; SCIATIC NERVE;

EID: 16244387203     PISSN: 02126982     EISSN: None     Source Type: Journal    
DOI: 10.1157/13071688     Document Type: Article

References (7)

1. Ben Arush MW, Israel O, Kedar Z, Goralnik L, Best LA, Meushar N, Elhasid R. Deteccion of isolated distant metastasis in soft tissue sarcoma by fluordeoxyglucose positron emission tomography: case report. Pediatr Hematol Oncol 2001;18:295-8.
2. Franzius C, Schulte M, Hillmann A, Winkelmann W, Jurgens H, Bockisch A, Schober O. Clinical value of positron emission tomography (PET) in the diagnosis of bone and soft tissue tumors. 3rd Interdisciplinary Consensus Conference PET in Oncology: results of the Bone and Soft Tissue Study Group. Chirurg 2001;72:1071-7.
3. Schwarz J, Beizberg AJ. Malignant peripheral nerve sheath tumors in the setting of segmental neurofibromatosis. Case report. J Neurosurg 2000;92:342-6.
4. Namyslowski G, Poloczek R, Pietrawska W, Urban I. Neurogenic sarcoma of the vagal nerve. Otolaryngol Pol 1998;52:615-7.
5. Ahmed AR, Watanabe H, Aoki J, Schinozaki T, Takagishi K. Schwannoma of the extremities: the role of PET in preoperative planning. Eur J Nucl Med 2001;28:1541-51.
6. Lodge MA, Lucas JD, Marsden PK, et al. A PET study off 18-FDG uptake in soft tissue masses. Eur J Nucl Med 1999;26:22-30.
7. Hain SF, O'Doherty MJ, Lucas JD, Smith MA. FDG-PET in the evaluation of amputations for soft tissue sarcoma. Nucl Med Commun 1999;20:845-8.